Search Results - "Silver, Lewis"
-
1
DICOMweb™: Background and Application of the Web Standard for Medical Imaging
Published in Journal of digital imaging (01-06-2018)“…This paper describes why and how DICOM, the standard that has been the basis for medical imaging interoperability around the world for several decades, has…”
Get full text
Journal Article -
2
Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure
Published in Clinical therapeutics (2004)“…Background: Prostaglandin analogues are effective ocular hypotensive agents and are being used increasingly in the treatment of elevated intraocular pressure…”
Get full text
Journal Article -
3
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis
Published in Annals of allergy, asthma, & immunology (01-12-2005)“…A nasal spray containing the antiallergy agent olopatadine hydrochloride is being developed for the treatment of seasonal allergic rhinitis (SAR). To evaluate…”
Get more information
Journal Article -
4
Ocular Comfort of Brinzolamide 1.0% Ophthalmic Suspension Compared With Dorzolamide 2.0% Ophthalmic Solution: Results From Two Multicenter Comfort Studies
Published in Survey of ophthalmology (2000)“…Two independent, prospective, multicenter, double-masked, parallel group trials were conducted to compare the ocular comfort of brinzolamide 1.0% administered…”
Get full text
Journal Article -
5
Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial
Published in Ophthalmology (Rochester, Minn.) (01-05-2002)“…To compare the safety and intraocular pressure (IOP)-lowering efficacy of once-daily travoprost (0.0015% and 0.004%) to twice-daily timolol 0.5%. Prospective,…”
Get more information
Journal Article -
6
Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension
Published in American journal of ophthalmology (01-09-1998)“…PURPOSE: To determine the intraocular pressure-lowering efficacy and safety of brinzolamide 1.0%, compared with dorzolamide 2.0% and timolol 0.5%. METHODS: A…”
Get full text
Journal Article -
7
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar
Published in Annals of allergy, asthma, & immunology (01-11-2005)“…A nasal spray containing the antiallergy agent olopatadine hydrochloride is being developed for the treatment of seasonal allergic rhinitis (SAR) to mountain…”
Get more information
Journal Article -
8
Clinical Safety of Moxifloxacin Ophthalmic Solution 0.5% (VIGAMOX®) in Pediatric and Nonpediatric Patients With Bacterial Conjunctivitis
Published in Survey of ophthalmology (01-11-2005)“…Five independent, multicentered, double-masked, parallel, controlled studies were conducted to determine the safety of moxifloxacin ophthalmic solution 0.5%…”
Get full text
Journal Article -
9
Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5
Published in American journal of ophthalmology (01-12-2001)“…PURPOSE: To evaluate the intraocular pressure-lowering efficacy and safety of travoprost 0.0015% and 0.004%, dosed daily in the evening compared with vehicle,…”
Get full text
Journal Article -
10
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1
Published in Ophthalmology (Rochester, Minn.) (01-08-2006)“…The safety and intraocular pressure (IOP)-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1 were evaluated and compared with…”
Get more information
Journal Article -
11
Identification and Characterization of the Ocular Hypotensive Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist, and AL-6598, a DP Prostaglandin Receptor Agonist
Published in Survey of Ophthalmology (01-08-2002)“…The structure-activity studies that led to the identification of travoprost, a highly selective and potent FP prostaglandin analog, and AL-6598, a DP…”
Get full text
Book Review Journal Article -
12
Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study
Published in American journal of ophthalmology (01-08-2000)“…PURPOSE: To evaluate the long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% (Timolol GFS 0.5%, Alcon…”
Get full text
Journal Article -
13
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
Published in American journal of ophthalmology (01-10-2001)“…PURPOSE: This study evaluated the safety and intraocular pressure–lowering efficacy of two concentrations of travoprost (0.0015% and 0.004%) compared with…”
Get full text
Journal Article -
14
Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt ®)
Published in Survey of ophthalmology (2000)“…Brinzolamide is a novel carbonic anhydrase inhibitor that elicits an ocular hypotensive effect when instilled topically. A multicenter, double-masked,…”
Get full text
Journal Article -
15
Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX®) in pediatric and nonpediatric patients with bacterial conjunctivitis: The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical ophthalmic fourth-generation fluoroquinolone
Published in Survey of ophthalmology (2005)Get full text
Journal Article -
16
Long-term intraocular pressure–lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with timoptic XE 0.5% in a 12-month study11All proprietary rights for this study are retained by Alcon Research, Ltd
Published in American journal of ophthalmology (01-08-2000)Get full text
Journal Article -
17
Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension
Published in Advances in therapy (01-05-2003)“…Two prospective, controlled, multicenter, double-masked studies--one lasting 6 months (n=594) and the other, 12 months (n=787)--examined the intraocular…”
Get full text
Journal Article -
18
Author reply
Published in American journal of ophthalmology (01-05-2002)Get full text
Journal Article -
19
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist: Update on the use of prostaglandin analogs in glaucoma therapy
Published in Survey of ophthalmology (2002)Get full text
Journal Article -
20
Effects of alcohols upon pacemaker activity in neurons ofAplysia californica
Published in Cellular and molecular neurobiology (01-09-1982)Get full text
Journal Article